NLS-12

N/A

Report date: 2024/09/18 13:32:21
NME

Base Information

Drug NameNLS-12
Drug Alias NameNLS-12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLewy Body Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNLS Pharmaceutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNLS Pharmaceutics Ltd
Inactive CompaniesN/A
Active IndicationsLewy Body Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A